Clinical Trial Update: Assessment of Valproate on Ethanol Withdrawal [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating valproate for ethanol withdrawal in individuals with alcohol-related disorders; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Alcohol Use Disorder
• Alcohol Withdrawal Syndrome

Drugs mentioned

• Valproate (valproate)

Snippet

Sponsor: CAMC Health System | Conditions: Alcohol Dependence, Alcohol Withdrawal Syndrome | Phase 4 | Status: UNKNOWN